SPLs dendrimer a potential viral conjunctivitis treatment
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- VivaGel condom receives TGA device certification
- VivaGel-coated condom approved for marketing in Japan
- Starpharma Interim Report and Half-year Financial Results
- Starpharma completes A$18 million placement, SPP to follow
- Starpharma commences Dendrimer-Docetaxel clinical trial
Later from Starpharma
- Dendrimers improve anticancer efficacy lung metastasis model
- SPL docetaxel superior to Taxotere across multiple cancers
- Starpharma presenting at Bell Potter LifeScience Conference
- Starpharma signs cancer drug agreement with AstraZeneca
- Starpharma to recoup $6 million cash for overseas R&D
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma